title: Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia.
authors.affiliation: Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, Guangdong , People's Republic of China.
authors.forename: Xiuzhen
authors.initials: X
authors.lastname: Tong
authors.forename: Juan
authors.initials: J
authors.lastname: Li
authors.forename: Zhenhai
authors.initials: Z
authors.lastname: Zhou
authors.forename: Dong
authors.initials: D
authors.lastname: Zheng
authors.forename: Junru
authors.initials: J
authors.lastname: Liu
authors.forename: Chang
authors.initials: C
authors.lastname: Su
mesh_terms: D000328:Adult; D000740:Anemia / Q000139:chemically induced; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002869:Chromosome Aberrations; D000077209:Decitabine; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013921:Thrombocytopenia / Q000139:chemically induced; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine